Advertisement

Topics

EMA adopts five product-specific bioequivalence guidelines

05:09 EDT 11 Aug 2017 | Generics and Biosimilars Initiative

The European Medicines Agency (EMA) has adopted five product-specific guidance documents on the demonstration of bioequivalence. The guidelines were published on 10 July 2017 and will become effective from 1 January 2018.

Original Article: EMA adopts five product-specific bioequivalence guidelines

NEXT ARTICLE

More From BioPortfolio on "EMA adopts five product-specific bioequivalence guidelines"

Quick Search
Advertisement